Pediatrix Medical Group Inc.

MD | NYSE

Price Alert Chart Builder DCF Calculator

$29.82

+$0.64 (+2.19%)

At close: Oct 30, 2026, 4:00 PM ET

$29.75

-$0.07 (-0.23%)

Pre-market: Nov 2, 2026, 5:29 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.19%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

44.5

-12.0 pts

Fundamentals Average

Market Sentiment Neutral

Moat Narrow

Sector Rank #407/1028 (Top 40%)

Full Analysis

Key Statistics

Market Data

Market Cap $2.42B

1D Range

29.07 29.99

52W Range

16.97 29.99

Valuation (TTM)

PE 16.21

PB 2.85

EV/EBITDA 10.44

Valuation (NTM)

Forward PE 11.36

Forward PEG 1.15

Price Target $26.60

Cash Flow

FCF Yield 8.7%

SBC Adj. FCF Yield 7.8%

SBC Impact -10.1%

Margins

Gross Margin 25.8%

Operating Margin 11.4%

FCF Margin 10.7%

Growth (CAGR)

Revenue 3Y | 5Y -0.9% | 1.4%

Dil EPS 3Y | 5Y 17.6% | 52.9%

FCF 3Y | 5Y 16.3% | 23.3%

Returns

ROA 7.0%

ROE 17.3%

ROIC 9.2%

Financial Health

Net Debt

$151.88M

Current Ratio 1.28

Interest Coverage 6.71

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonata...

Sector Healthcare

Industry Medical - Care Facilities

Employees 4,280

IPO Date Sep 20, 1995

Website www.pediatrix.com

Fiscal Year January - December

Full Company Profile

Latest News

3 days ago · marketbeat.com

What Pediatrix Medical Group (MD) Said on Its Q3 Earnings Call

Pediatrix Medical Group NYSE: MD reported third-quarter 2026 adjusted EBITDA of $85 million, with management saying results exceeded its expectations despite rising costs across healthcare delivery. The company narrowed its full-year adjusted EBITDA outlook to a range of $290 million to $300 million.

3 days ago · seekingalpha.com

Pediatrix Medical Group, Inc. (MD) Q3 2026 Earnings Call Transcript

Pediatrix Medical Group, Inc. ( MD ) Q3 2026 Earnings Call October 29, 2026 9:00 AM EDT Company Participants David Haddock - Executive Vice President, General Counsel & Secretary Mark Ordan - CEO & Executive Chairman Kasandra Rossi - Executive VP, Treasurer & CFO Conference Call Participants Matthew Mardula - William Blair & Company L.L.C., Research Division Albert Rice - UBS Investment Bank, Research Division Jack Slevin - Jefferies LLC, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Pito Chickering - Deutsche Bank AG, Research Division Presentation Operator Hello, and thank you for standing by.

4 days ago · zacks.com

Pediatrix Medical Group (MD) Beats Q3 Earnings and Revenue Estimates

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.67 per share a year ago.

4 days ago · businesswire.com

Pediatrix Medical Group Reports Third Quarter Results

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Third Quarter Results.

13 days ago · businesswire.com

Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026.

24 days ago · zacks.com

Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

1 month ago · zacks.com

Can Pediatrix Sustain Growth Despite Lower Patient Volumes?

MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.